These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27121091)

  • 1. Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
    Jin L; Li Y; Liu J; Yang S; Gui Y; Mao X; Nie G; Lai Y
    Mol Med Rep; 2016 Jun; 13(6):5386-92. PubMed ID: 27121091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma.
    Chen D; Li Y; Yu Z; Li Y; Su Z; Ni L; Yang S; Gui Y; Lai Y
    Mol Med Rep; 2015 Aug; 12(2):3061-6. PubMed ID: 25936999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
    Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
    Li Y; Jin L; Chen D; Liu J; Su Z; Yang S; Gui Y; Mao X; Nie G; Lai Y
    Mol Med Rep; 2016 Jul; 14(1):560-6. PubMed ID: 27175581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of miR‑125a‑5p as a tumor suppressor of renal cell carcinoma, regulating cellular proliferation, migration and apoptosis.
    Chen D; Li Y; Su Z; Yu Z; Yu W; Li Y; Gui Y; Yang S; Lai Y
    Mol Med Rep; 2015 Feb; 11(2):1278-83. PubMed ID: 25370896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
    Li Y; Quan J; Chen F; Pan X; Zhuang C; Xiong T; Zhuang C; Li J; Huang X; Ye J; Zhang F; Zhang Z; Gui Y
    Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
    Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
    Zhai Q; Zhou L; Zhao C; Wan J; Yu Z; Guo X; Qin J; Chen J; Lu R
    Biochem Biophys Res Commun; 2012 Mar; 419(4):621-6. PubMed ID: 22369946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
    Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
    DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.
    Zhang WB; Pan ZQ; Yang QS; Zheng XM
    Ir J Med Sci; 2013 Dec; 182(4):621-7. PubMed ID: 23619562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
    Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
    Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR‑15a‑5p acts as an oncogene in renal cell carcinoma.
    Jin L; Li Y; He T; Hu J; Liu J; Chen M; Zhang Z; Gui Y; Mao X; Yang S; Lai Y
    Mol Med Rep; 2017 Mar; 15(3):1379-1386. PubMed ID: 28098906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑660‑5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma.
    He T; Chen P; Jin L; Hu J; Li Y; Zhou L; Yang S; Mao X; Gui Y; Chen Y; Lai Y
    Mol Med Rep; 2018 Jan; 17(1):2051-2060. PubMed ID: 29138826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C; Wang S; Ye ZQ; Chen ZQ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
    Lu R; Ji Z; Li X; Zhai Q; Zhao C; Jiang Z; Zhang S; Nie L; Yu Z
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):387-97. PubMed ID: 24384875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-411 functions as a tumor suppressor in renal cell cancer.
    Zhang X; Zhang M; Cheng J; Lv Z; Wang F; Cai Z
    Int J Biol Markers; 2017 Oct; 32(4):e454-e460. PubMed ID: 28708205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑24‑2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma.
    Jin L; Li Y; Nie L; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Lai Y
    Mol Med Rep; 2017 Dec; 16(6):9157-9164. PubMed ID: 28990105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.